Summary
Global Markets Direct’s, ‘Anacor Pharmaceuticals, Inc. - Product Pipeline Review - 2016’, provides an overview of the Anacor Pharmaceuticals, Inc.’s pharmaceutical research and development focus.
The report provides comprehensive information on the therapeutics under development by Anacor Pharmaceuticals, Inc., complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and the dormant and discontinued projects.
Global Markets Direct’s report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct’s proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.
The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.
Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data.
Scope
- The report provides a snapshot of the pipeline therapeutic landscape of Anacor Pharmaceuticals, Inc.
- The report provides overview of Anacor Pharmaceuticals, Inc. including its business description, key facts, and locations and subsidiaries
- The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities
- The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages
- The report assesses Anacor Pharmaceuticals, Inc.’s pipeline therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA) and molecule type
- The report features Anacor Pharmaceuticals, Inc.’s out-licensed and partnered product portfolio and summarizes its dormant and discontinued projects
Reasons to buy
- Evaluate Anacor Pharmaceuticals, Inc.’s strategic position with total access to detailed information on its product pipeline
- Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Identify and understand important and diverse types of therapeutics under development for Anacor Pharmaceuticals, Inc.
- Identify potential new clients or partners in the target demographic
- Plan mergers and acquisitions effectively by identifying key players and it’s most promising pipeline therapeutics
- Devise corrective measures for pipeline projects by understanding Anacor Pharmaceuticals, Inc.’s pipeline depth and focus of pipeline therapeutics
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
'
Table of Contents
Table of Contents 2
List of Tables 5
List of Figures 5
Anacor Pharmaceuticals, Inc. Snapshot 6
Anacor Pharmaceuticals, Inc. Overview 6
Key Information 6
Key Facts 6
Anacor Pharmaceuticals, Inc. - Research and Development Overview 7
Key Therapeutic Areas 7
Anacor Pharmaceuticals, Inc. - Pipeline Review 10
Pipeline Products by Stage of Development 10
Pipeline Products - Monotherapy 11
Pipeline Products - Out-Licensed Products 12
Out-Licensed Products/Combination Treatment Modalities 13
Anacor Pharmaceuticals, Inc. - Pipeline Products Glance 14
Anacor Pharmaceuticals, Inc. - Late Stage Pipeline Products 14
Pre-Registration Products/Combination Treatment Modalities 14
Anacor Pharmaceuticals, Inc. - Clinical Stage Pipeline Products 15
Phase II Products/Combination Treatment Modalities 15
Phase I Products/Combination Treatment Modalities 16
Anacor Pharmaceuticals, Inc. - Early Stage Pipeline Products 17
Preclinical Products/Combination Treatment Modalities 17
Discovery Products/Combination Treatment Modalities 18
Anacor Pharmaceuticals, Inc. - Drug Profiles 19
crisaborole 19
Product Description 19
Mechanism of Action 19
R&D Progress 19
epetraborole 21
Product Description 21
Mechanism of Action 21
R&D Progress 21
AN-2718 23
Product Description 23
Mechanism of Action 23
R&D Progress 23
AN-3485 24
Product Description 24
Mechanism of Action 24
R&D Progress 24
AN-4161 25
Product Description 25
Mechanism of Action 25
R&D Progress 25
AN-4169 26
Product Description 26
Mechanism of Action 26
R&D Progress 26
AN-5973 27
Product Description 27
Mechanism of Action 27
R&D Progress 27
Small Molecule 1 for Tuberculosis 28
Product Description 28
Mechanism of Action 28
R&D Progress 28
Small Molecule 2 for Tuberculosis 29
Product Description 29
Mechanism of Action 29
R&D Progress 29
Small Molecule for Shigellosis 30
Product Description 30
Mechanism of Action 30
R&D Progress 30
Small Molecules for Chagas Disease 31
Product Description 31
Mechanism of Action 31
R&D Progress 31
Small Molecules for Leishmaniasis 32
Product Description 32
Mechanism of Action 32
R&D Progress 32
Small Molecules for Nematodal Diseases 33
Product Description 33
Mechanism of Action 33
R&D Progress 33
Small Molecules for Skin Inflammation 34
Product Description 34
Mechanism of Action 34
R&D Progress 34
Small Molecules to Inhibit PDE4 for Psoriasis 35
Product Description 35
Mechanism of Action 35
R&D Progress 35
Anacor Pharmaceuticals, Inc. - Pipeline Analysis 36
Anacor Pharmaceuticals, Inc. - Pipeline Products by Target 36
Anacor Pharmaceuticals, Inc. - Pipeline Products by Route of Administration 37
Anacor Pharmaceuticals, Inc. - Pipeline Products by Molecule Type 38
Anacor Pharmaceuticals, Inc. - Pipeline Products by Mechanism of Action 39
Anacor Pharmaceuticals, Inc. - Recent Pipeline Updates 40
Anacor Pharmaceuticals, Inc. - Dormant Projects 45
Anacor Pharmaceuticals, Inc. - Discontinued Pipeline Products 46
Discontinued Pipeline Product Profiles 46
epetraborole 46
Anacor Pharmaceuticals, Inc. - Locations And Subsidiaries 47
Head Office 47
Appendix 48
Methodology 48
Coverage 48
Secondary Research 48
Primary Research 48
Expert Panel Validation 48
Contact Us 48
Disclaimer 49
List of Tables
Anacor Pharmaceuticals, Inc., Key Information 6
Anacor Pharmaceuticals, Inc., Key Facts 6
Anacor Pharmaceuticals, Inc. - Pipeline by Indication, 2016 8
Anacor Pharmaceuticals, Inc. - Pipeline by Stage of Development, 2016 10
Anacor Pharmaceuticals, Inc. - Monotherapy Products in Pipeline, 2016 11
Anacor Pharmaceuticals, Inc. - Out-Licensed Products in Pipeline, 2016 12
Anacor Pharmaceuticals, Inc. - Out-Licensed Products/ Combination Treatment Modalities, 2016 13
Anacor Pharmaceuticals, Inc. - Pre-Registration, 2016 14
Anacor Pharmaceuticals, Inc. - Phase II, 2016 15
Anacor Pharmaceuticals, Inc. - Phase I, 2016 16
Anacor Pharmaceuticals, Inc. - Preclinical, 2016 17
Anacor Pharmaceuticals, Inc. - Discovery, 2016 18
Anacor Pharmaceuticals, Inc. - Pipeline by Target, 2016 36
Anacor Pharmaceuticals, Inc. - Pipeline by Route of Administration, 2016 37
Anacor Pharmaceuticals, Inc. - Pipeline by Molecule Type, 2016 38
Anacor Pharmaceuticals, Inc. - Pipeline Products by Mechanism of Action, 2016 39
Anacor Pharmaceuticals, Inc. - Recent Pipeline Updates, 2016 40
Anacor Pharmaceuticals, Inc. - Dormant Developmental Projects,2016 45
Anacor Pharmaceuticals, Inc. - Discontinued Pipeline Products, 2016 46
List of Figures
Anacor Pharmaceuticals, Inc. - Pipeline by Top 10 Indication, 2016 8
Anacor Pharmaceuticals, Inc. - Pipeline by Stage of Development, 2016 10
Anacor Pharmaceuticals, Inc. - Monotherapy Products in Pipeline, 2016 11
Anacor Pharmaceuticals, Inc. - Out-Licensed Products in Pipeline, 2016 12
Anacor Pharmaceuticals, Inc. - Pipeline by Target, 2016 36
Anacor Pharmaceuticals, Inc. - Pipeline by Route of Administration, 2016 37
Anacor Pharmaceuticals, Inc. - Pipeline by Molecule Type, 2016 38
Anacor Pharmaceuticals, Inc. - Pipeline Products by Mechanism of Action, 2016 39
